Year None20222021202020192018 May 12, 2022 - Zymergen Reports Preliminary First Quarter 2022 Financial Results PDF Version April 29, 2022 - Zymergen to Participate in the BofA Securities 2022 Healthcare Conference PDF Version April 13, 2022 - Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022 PDF Version March 22, 2022 - Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results PDF Version March 16, 2022 - Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022 PDF Version March 6, 2022 - Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing PDF Version February 28, 2022 - Zymergen to Participate in the 42nd Annual Cowen Healthcare Conference PDF Version January 10, 2022 - Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare Conference PDF Version January 9, 2022 - Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform PDF Version January 5, 2022 - Zymergen to Present at the 40th Annual J.P. Morgan Healthcare Conference PDF Version
April 29, 2022 - Zymergen to Participate in the BofA Securities 2022 Healthcare Conference PDF Version
April 13, 2022 - Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022 PDF Version
March 22, 2022 - Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results PDF Version
March 16, 2022 - Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022 PDF Version
March 6, 2022 - Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing PDF Version
February 28, 2022 - Zymergen to Participate in the 42nd Annual Cowen Healthcare Conference PDF Version
January 10, 2022 - Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare Conference PDF Version
January 9, 2022 - Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform PDF Version
January 5, 2022 - Zymergen to Present at the 40th Annual J.P. Morgan Healthcare Conference PDF Version
